会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • PLANT-BASED RECOMBINANT BUTYRYLCHOLINESTERASE PRODUCTION METHODS
    • 基于植物的重组丁基胆碱酯酶生产方法
    • US20150184138A1
    • 2015-07-02
    • US14448545
    • 2014-07-31
    • Greg PogueErnie HiattRomy KandziaStefan WernerFrank ThiemeTsafrir Mor
    • Greg PogueErnie HiattRomy KandziaStefan WernerFrank ThiemeTsafrir Mor
    • C12N9/18A61K38/46
    • C12N9/18A61K38/465C12Y301/01008
    • A new, reliable, easily scalable and reproducible method for the production of recombinant butyrylcholinesterase (rBuChE) is provided. Through the utilization of a plant transfection procedure, various plant strains have been shown to generate effective and scalable amounts of rBuChE under acceptable manufacturing processes to permit reliable levels of such enzymes for desired nerve agent protection requirements (including tetrameric products). As well, such methods in engineered plant lines have shown suitable production of these enzymes in tetramer form with glycan formation and sialyalation (for terminal groups) to allow for optimal potency against organophosphorus agent exposure as well as proper immunogenic response within the plant sources. The overall production method, including the transfection and production within mammalian cells, as well as the process steps involved for such a reliable sourcing platform from plants is thus encompassed within the invention.
    • 提供了一种用于生产重组丁酰胆碱酯酶(rBuChE)的新的,可靠的,易于扩展和重现的方法。 通过利用植物转染方法,已经显示各种植物菌株在可接受的制造过程中产生有效和可缩放量的rBuChE,以允许可靠水平的这些酶用于所需的神经药物保护要求(包括四聚物产品)。 同样,工程化植物品系中的这些方法已经显示出以四聚体形式合适地生产这些酶,其中聚糖形成和sialyalation(用于末端基团)以允许针对有机磷剂暴露的最佳效力以及在植物来源内的适当的免疫原性反应。 因此,包括哺乳动物细胞内的转染和生产的总体生产方法以及从植物获得这种可靠的采购平台所涉及的工艺步骤。
    • 8. 发明申请
    • SYSTEM AND METHOD OF MODULAR CLONING
    • US20130267021A1
    • 2013-10-10
    • US13703123
    • 2011-06-09
    • Ernst WeberStefan WernerCarola EnglerRamona GrütznerSylvestre Marillonnet
    • Ernst WeberStefan WernerCarola EnglerRamona GrütznerSylvestre Marillonnet
    • C12N15/66
    • C12N15/66C12N15/1093
    • System for producing a nucleic acid construct of interest, said system comprising: a set of n entry DNAs numbered 1 to n, n being an integer of at least 2, each of said n entry DNAs comprising in this order: (i) a type IIs restriction endonuclease recognition site followed by the cleavage site thereof; (ii) a sequence portion linking the cleavage site of said recognition site of item (i) with the cleavage site of the recognition site of the following item (iii), and (iii) a cleavage site of a further type Ms restriction endonuclease recognition site followed by the recognition site of said cleavage site; the cleavage sites of the type IIs restriction endonuclease recognition sites of item (iii) of entry DNAs 1 to n−1 are complementary to the cleavage sites of the type IIs restriction endonuclease recognition sites of item (i) of entry DNAs 2 to n, respectively; the cleavage site of the type Ms restriction endonuclease recognition site of item (iii) of entry DNA n is complementary to the cleavage site of the type IIs restriction endonuclease recognition site of item (i) of entry DNA 1 for allowing annealing of complementary single-stranded overhangs formed by restriction at recognition site (i) of entry DNA 1 and at recognition site (iii) of entry DNA n; said system further comprising a destination vector comprising in this order: (I) a type Ms restriction endonuclease recognition site followed by the cleavage site thereof; (II) a vector backbone preferably comprising a selectable marker gene, said vector backbone linking the cleavage sites of said recognition sites of items (I) and the following item (III); (III) a further cleavage site of a type Ms restriction endonuclease recognition site followed by the recognition site of said cleavage site, and (IV) optionally, an insert between the recognition sites of item (III) and item (i); said cleavage sites of items (I) and (III) being different and non-complementary, said recognition sites of items (I) and (III) being preferably recognitions sites of the same endonuclease.
    • 10. 发明申请
    • PROCESS OF CLEAN CLONING
    • 清洁过程
    • US20110263024A1
    • 2011-10-27
    • US13121019
    • 2009-10-08
    • Sylvestre MarillonnetStefan WernerCarola EnglerRomy KandziaFrank ThiemeErnst Weber
    • Sylvestre MarillonnetStefan WernerCarola EnglerRomy KandziaFrank ThiemeErnst Weber
    • C12N15/87
    • C12N15/64C12N15/66
    • A process of inserting a nucleic acid sequence of interest into an acceptor nucleic acid, comprising the following steps: amplifying by PCR a DNA comprising in the following order a sequence segment U, a nucleic acid sequence segment of known nucleotide sequence K2 and a nucleic acid sequence segment of known sequence K3 using a forward primer defining a first end of the amplified DNA and a reverse primer defining a second end of the amplified DNA, said reverse primer terminating at its 3′-end in a nucleotide sequence of nucleic acid sequence segment K3; treating the linear double-stranded DNA molecules contained in the PCR product obtained in the previous step with an exonuclease to obtain a single-stranded overhang at the first end of the DNA and a single-stranded overhang comprising nucleic acid segments K2 and K3 at the second end of the DNA; and annealing the product of the previous step to a linearized double-stranded acceptor nucleic acid having at a first end thereof a single-stranded overhang complementary to the single-stranded overhang of the first end of the DNA and at a second end thereof a single-stranded overhang complementary to the single-stranded sequence segment K2 of the second end of the DNA.
    • 包括以下步骤:通过PCR扩增包含以下顺序的DNA序列的已知核苷酸序列K2的核酸序列片段和核酸的方法 已知序列K3的序列片段使用限定扩增DNA第一末端的正向引物和限定扩增DNA第二末端的反向引物,所述反向引物在其核酸序列片段的核苷酸序列的3'末端终止 K3; 用外切核酸酶处理前一步骤中获得的PCR产物中包含的线性双链DNA分子,以在DNA的第一端获得单链突出端,并且在第一端包含核酸片段K2和K3的单链突出端 DNA的第二端; 并将前述步骤的产物退火到线性双链受体核酸,其在第一端具有与DNA的第一末端的单链突出部互补的单链突出端,并且在其第二端具有单链突出端 与DNA的第二末端的单链序列片段K2互补的突出突出端。